心,功能障碍,心房结节阻塞,冲击和高血症 (BRASH) 综合征:临床特征,结果和治疗影响
Mariana Esteves1, Rita Bragança1, Sandra Morais2
1Internal Medicine, Unidade Local de Saúde de Trás-os-Montes e Alto Douro, Vila Real, PRT.
Cureus
|February 23, 2026
概括
在老年患者中,BRASH综合征,一种表现为胸,功能障碍,AV节点阻塞剂使用,休克和高血症的模式,被低诊断. 早期识别对于管理血液动力学损害和器官支持需求至关重要.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 关键护理医学 关键护理医学
背景情况:
- BRASH综合征 (胸,功能障碍,AV节点阻塞剂使用,休克,高血症) 是一种被诊断不足的疾病,特别是在患有并发症的老年患者中.
- 关于BRASH综合征的临床表现,管理和结果的数据有限.
研究的目的:
- 描述BRASH综合征患者的临床特征,诱发因素,管理策略和短期结果.
- 强调早期识别和干预BRASH综合征的重要性.
主要方法:
- 从2019年到2022年进行了一项单中心回顾性队列研究.
- 包括在内的患者满足了胸肌梗塞,高胆血症 (K+≥5.0 mmol/L),急性损伤,AV节点阻塞剂使用和休克的标准.
- 分析了人口统计,并发症,诱发因素,治疗方法和结果.
主要成果:
- 包括51名老年患者 (平均年龄为79.8岁),患有高血压和心力衰竭等常见并发症.
- 常见的诱发因素包括毒性暴露,感染/败血症以及AV节点阻塞剂的启动/升级.
- 治疗包括,胰岛素/乳糖,β-激动剂,血管压缩剂和置换疗法;住院死亡率为15.7%.
结论:
- BRASH综合征需要早期识别,因为可能存在显著的血液动力学损害.
- 在高危患者中,即使是中度的高卡利米亚也可能导致严重的并发症,需要器官支持.
- 及时识别和管理对于改善BRASH综合征患者的治疗结果至关重要.
关键词:
急性脏损伤急性脏损伤是什么内心心室结节的阻塞胸肌梗塞是什么意思 胸肌梗塞是什么意思布拉什综合征是什么意思年长的病人,老年患者.血清过高的高卡利米亚.多种药房多种药房冲击 冲击 冲击 冲击 冲击 冲击更多相关视频
相关概念视频
Dysrhythmias IV: Characteristics of Bradyarrhythmias
646
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
646
Decreased pulse rate
952
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
952
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
2.1K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.1K
Disturbances in Heart Rhythm
3.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.3K
Cardiopulmonary Resuscitation IV: Pharmacological Management
983
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
983


